Loading organizations...
ATON Partners operates as a specialized management consulting firm dedicated to the medical technology sector. The firm leverages extensive real-world knowledge to guide the development and commercialization of innovative medical devices and diagnostics technologies. Their approach integrates deep industry insights with practical operational strategies, focusing on advancing early-concept stage technologies through to successful market entry and expansion.
The firm was founded by Patrick Sullivan and Daniel Levangie, who brought over two decades of operating experience from leading highly successful medical device and diagnostics companies. Their founding insight stemmed from the recognition that their hands-on expertise in building and exiting ventures could provide critical support to emerging medical technology companies, translating complex ideas into tangible, market-ready products.
ATON Partners primarily serves inventors and entrepreneurs within the medical technology landscape. The company’s long-term vision centers on fostering the growth of promising medical innovations by providing guidance through the intricacies of commercialization, navigating international markets, addressing regulatory challenges, and managing investor relations, ultimately aiming to bring impactful healthcare solutions to patients globally.
ATON Partners has 1 tracked investment across 1 company. The latest tracked deal is $44.0M Series A in CereVasc in June 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2020 | CereVasc | $44.0M Series A | Perceptive Advisors, Aton Partners | Rapha Capital Management |